Development and Commercialization Reporting Sample Clauses
Development and Commercialization Reporting. At the written request of the Inventors, within 30 days of the end of each Quarterly Period, PTL shall deliver a written report summarizing its, its Affiliates and its Sublicensees’ efforts during the prior Quarterly Period to develop and commercialize Products, including: (a) research and development activities completed; (b) commercialization and/or other distribution efforts, including significant corporate transactions involving Products; and (c) marketing efforts. Each report must contain a sufficient level of detail for the Inventors to assess whether PTL is in compliance with its obligations under Section 3.1 and a discussion of intended efforts for the then current year.
Development and Commercialization Reporting. During the Alliance Term, and within [***] ([***]) [***], Company shall provide ▇▇▇▇▇▇▇ CCRI with a written report summarizing in reasonable detail its Development and, as applicable, Manufacturing and Commercialization activities conducted during the preceding calendar year. Each report shall outline in reasonable detail the current status of Development activities, including regulatory activities and the current status of Manufacturing and Commercialization activities. Each such report shall cover the full period since the end of the reporting period covered by the previous report. Upon expiry of the Alliance Term, the reporting obligations under this Section 6.6(c) shall (i) survive such expiry, (ii) convert into [***]reporting obligations and (iii) continue until the earlier of (A) [***] and (B) [***] ([***]) [***] the date that Company is no longer engaged in any Development, Manufacturing or Commercialization activities with respect to any TIL Product. Execution Copy
Development and Commercialization Reporting. Beginning on March 31 of the Calendar Year following the end of the Transition Period, and on each such anniversary thereafter prior to the date on which the first report is due under Section 6.5, Ultragenyx will submit to Abeona a written report summarizing Ultragenyx’s material Development and Commercialization activities with respect to the Licensed Products pursuant to this Agreement since the date of Ultragenyx’s delivery of the prior report, and, with respect to the first of such reports, since the Effective Date.
Development and Commercialization Reporting